These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 2674603)
21. Comparative genotoxic evaluation of 2-furylethylenes and 5-nitrofurans by using the comet assay in TK6 cells. González Borroto JI; Pérez Machado G; Creus A; Marcos R Mutagenesis; 2005 May; 20(3):193-7. PubMed ID: 15817571 [TBL] [Abstract][Full Text] [Related]
22. 32P Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent. Peluso M; Castegnaro M; Malaveille C; Friesen M; Garren L; Hautefeuille A; Vineis P; Kadlubar F; Bartsch H Carcinogenesis; 1991 Apr; 12(4):713-7. PubMed ID: 2013135 [TBL] [Abstract][Full Text] [Related]
24. Influence of subcellular fractions of mammalian testes on the mutagenic activity of nitrofurans toward Escherichia coli; presence of a co-mutagen-like factor. Maier P; Philpot RM; Mohn GR; Malling HV Mutat Res; 1979 Dec; 63(2):233-43. PubMed ID: 118378 [TBL] [Abstract][Full Text] [Related]
25. DNA damage by 5-nitro-2-furylacrylic acid, a nitrofuran derivative. Chatterjee SN; Banerjee SK; Pal AK; Basak J Chem Biol Interact; 1987; 63(2):185-94. PubMed ID: 3311411 [TBL] [Abstract][Full Text] [Related]
26. Detection by 32P-postlabelling of DNA adducts induced by free radicals and unsaturated aldehydes formed during the aerobic decomposition of fecapentaene-12. Povey AC; Wilson VL; Zweier JL; Kuppusamy P; O'Neill IK; Harris CC Carcinogenesis; 1992 Mar; 13(3):395-401. PubMed ID: 1547529 [TBL] [Abstract][Full Text] [Related]
27. Site-specific frame-shift mutagenesis by the 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-y1)-1-aminopyrene located in the (CG)3 sequence: effects of SOS, proofreading, and mismatch repair. Malia SA; Vyas RR; Basu AK Biochemistry; 1996 Apr; 35(14):4568-77. PubMed ID: 8605207 [TBL] [Abstract][Full Text] [Related]
28. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach. Eder E; Schuler D; Budiawan IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223 [TBL] [Abstract][Full Text] [Related]
29. Application of the 32P-postlabelling assay to the inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-DNA adduct formation by dietary fatty acids. Schut HA; Zu HX IARC Sci Publ; 1993; (124):181-8. PubMed ID: 8225482 [TBL] [Abstract][Full Text] [Related]
30. The action of 1-nitroso-8-nitropyrene in Escherichia coli: DNA adduct formation and mutational consequences in the absence of nucleotide excision-repair. Lambert IB; Gordon AJ; Bryant DW; Glickman BW; McCalla DR Carcinogenesis; 1991 May; 12(5):879-84. PubMed ID: 2029753 [TBL] [Abstract][Full Text] [Related]
31. Formation of thymidine adducts and cross-linking potential of 2-bromoacrolein, a reactive metabolite of tris(2,3-dibromopropyl)phosphate. van Beerendonk GJ; Nivard MJ; Vogel EW; Nelson SD; Meerman JH Mutagenesis; 1992 Jan; 7(1):19-24. PubMed ID: 1635451 [TBL] [Abstract][Full Text] [Related]
32. Spectrum of cisplatin-induced mutations in Escherichia coli. Burnouf D; Duane M; Fuchs RP Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3758-62. PubMed ID: 3295870 [TBL] [Abstract][Full Text] [Related]
33. Identification of the major hepatic DNA adduct formed by the food mutagen 2-amino-9H-pyrido[2,3-b]indole (A alpha C). Pfau W; Schulze C; Shirai T; Hasegawa R; Brockstedt U Chem Res Toxicol; 1997 Oct; 10(10):1192-7. PubMed ID: 9348443 [TBL] [Abstract][Full Text] [Related]
34. Principles of covalent binding of reactive metabolites and examples of activation of bis-electrophiles by conjugation. Guengerich FP Arch Biochem Biophys; 2005 Jan; 433(2):369-78. PubMed ID: 15581593 [TBL] [Abstract][Full Text] [Related]
35. ³²P-postlabelling for the sensitive detection of DNA adducts. Jones NJ Methods Mol Biol; 2012; 817():183-206. PubMed ID: 22147574 [TBL] [Abstract][Full Text] [Related]
36. Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysis. Debnath AK; Hansch C; Kim KH; Martin YC J Med Chem; 1993 Apr; 36(8):1007-16. PubMed ID: 8478900 [TBL] [Abstract][Full Text] [Related]
37. Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. White IN; de Matteis F; Davies A; Smith LL; Crofton-Sleigh C; Venitt S; Hewer A; Phillips DH Carcinogenesis; 1992 Dec; 13(12):2197-203. PubMed ID: 1473224 [TBL] [Abstract][Full Text] [Related]
38. Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II). Yarema KJ; Lippard SJ; Essigmann JM Nucleic Acids Res; 1995 Oct; 23(20):4066-72. PubMed ID: 7479066 [TBL] [Abstract][Full Text] [Related]
39. Boronic acids-a novel class of bacterial mutagen. O'Donovan MR; Mee CD; Fenner S; Teasdale A; Phillips DH Mutat Res; 2011 Sep; 724(1-2):1-6. PubMed ID: 21645632 [TBL] [Abstract][Full Text] [Related]
40. Mutation spectrum of the mutagen 3-N,N-acetoxyacetylamino-4,6-dimethyldipyrido[1,2-a:3',2'- d]imidazole in Escherichia coli. Hebert E; Diancourt F; Saint-Ruf G; Leng M Carcinogenesis; 1988 Jan; 9(1):183-5. PubMed ID: 3275503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]